{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T05:04:27Z","timestamp":1696655067543},"reference-count":4,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2007,6,22]],"date-time":"2007-06-22T00:00:00Z","timestamp":1182470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl J Gynecology &amp; Obste"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.ijgo.2007.05.008","type":"journal-article","created":{"date-parts":[[2007,6,23]],"date-time":"2007-06-23T11:08:37Z","timestamp":1182596917000},"page":"162-163","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of adjuvant endocrine therapy on the prognosis of endometrial carcinoma confined to the uterus"],"prefix":"10.1002","volume":"98","author":[{"given":"Zhiqi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianliu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,6,22]]},"reference":[{"issue":"34","key":"e_1_2_2_2_2","first-page":"2414","article-title":"Clinical significance of adjuvant endocrine therapy in treatment of endometrialcarcinoma: study of 171 patients [In Chinese]","volume":"85","author":"Wang Z.Q.","year":"2005","journal-title":"Zhonghua YiXue ZaZhi"},{"key":"e_1_2_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(02)00378-7"},{"key":"e_1_2_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(92)90142-6"},{"issue":"2","key":"e_1_2_2_5_2","first-page":"150","article-title":"Favourable influence of adjuvant hormone therapy by oxyprogesterone caproate (OPC) and by its combination with tamoxifen of 5\u2010year survival rate of surgical and combined treatment of primary endometrial carcinoma patients","volume":"14","author":"Vishnevsky A.S.","year":"1993","journal-title":"Eur J Gynaecol Oncol"}],"container-title":["International Journal of Gynecology &amp; Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0020729207002858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0020729207002858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1016%2Fj.ijgo.2007.05.008","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1016%2Fj.ijgo.2007.05.008","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1016\/j.ijgo.2007.05.008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T08:17:00Z","timestamp":1696580220000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1016\/j.ijgo.2007.05.008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,22]]},"references-count":4,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["10.1016\/j.ijgo.2007.05.008"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgo.2007.05.008","archive":["Portico"],"relation":{},"ISSN":["0020-7292","1879-3479"],"issn-type":[{"value":"0020-7292","type":"print"},{"value":"1879-3479","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,22]]}}}